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Bone morphogenetic protein (Bmp) signaling is critical for the development and patterning of the mouse pituitary from the initial induction of
Rathke’s pouch to cell specification in the anterior lobe. We examined the regulation of Bmp signaling during pituitary development by analyzing
null embryos for noggin, a Bmp 2 and 4 antagonist. Noggin is expressed in the ventral diencephalon during Rathke’s pouch induction, in the
underlying cartilage plate during cell specification and in the adult anterior pituitary gland. Noggin null embryos have a variable pituitary
phenotype, which ranges from a rostrally displaced Rathke’s pouch to induction of secondary pituitary tissue. While cell specification in the
anterior pituitary appears normal, patterning in the ventral diencephalon is disrupted; Bmp4 activity is expanded resulting in Fibroblast growth
factor 10 repression and in a rostral shift in the boundary between the Bmp4 and Sonic hedgehog expression domains. The expanded domain of
Bmp4 activity also results in additional invaginations of oral ectoderm and can shift the position of Rathke’s pouch or create secondary pituitary
tissue. This work demonstrates the importance of attenuating the activity of Bmp signaling during pituitary induction in order to maintain the
proper balance of signaling factors necessary for pituitary organogenesis.
© 2007 Elsevier Inc. All rights reserved.Keywords: Ventral diencephalon; Rathke’s pouch; Dorsal–ventral patterning; Ectopic pituitary glandIntroduction
Signaling molecules such as bone morphogenetic protein
(BMP), fibroblast growth factor (FGF), Hedgehog, Notch and
Wnt are instrumental for the development of a diverse array of
mammalian organs including the pituitary gland. In most organs
there is evidence that multiple signaling pathways are operative
and interact positively and negatively to direct organogenesis.
For instance, Wnt signaling negatively regulates branching
morphogenesis in the lung by inhibiting the activity of Bmp and
Fgf, which promote branching (Dean et al., 2005). In the third
pharyngeal arch, Sonic Hedgehog (Shh) and Bmp antagonize
each other during the development of the parathyroid and
thymus (Moore-Scott and Manley, 2005). In the pituitary, Bmp
and Fgf signaling are thought to antagonize each other during
pituitary cell specification (Ericson et al., 1998; Treier et al.,
1998). Wnt, Shh and Notch signaling are also important for
pituitary development and can affect organ shape (Cha et al.,
2004), proliferation (Treier et al., 2001) and cell specification⁎ Corresponding author. Fax: +1 734 763 5831.
E-mail address: scamper@umich.edu (S.A. Camper).
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doi:10.1016/j.ydbio.2007.02.001(Raetzman et al., 2004; Treier et al., 1998, 2001). The challenge
now is to determine how these various signaling pathways
interact with each other during organogenesis in general, and
also within the developing pituitary.
Chick/quail fate maps originally localized the origin of the
pituitary to the midline of the anterior neural ridge in a region
adjacent to the future ventral diencephalon (Couly and Le
Douarin, 1988). More recent work has also identified
homologous regions in zebrafish anterior neural ridge that
harbor pituitary precursors (Dutta et al., 2005). More lateral
regions in the anterior neural ridge give rise to the sensory
placodes of the eyes and ears. Recent work in the chicken has
shown that the precise integration of Wnt, Bmp and Fgf
signaling is necessary for specifying this pre-placodal region
that arises from the anterior neural ridge (Litsiou et al., 2005).
The specification of the pre-placodal region requires the
attenuation of Bmp and Wnt signals. The Bmp antagonist
Neuroblastoma, suppressor of tumorigenicity 1 (Nbl1 also
known as DAN) and the Bmp and Wnt antagonist Cerberus are
thought to mediate this attenuation (Litsiou et al., 2005),
highlighting the roles that secreted antagonists play in
modulating the activity of signaling factors.
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continue to play important roles in the development and
function of the pituitary. In mice, the pituitary is comprised of
anterior, intermediate and posterior lobes. The anterior and
intermediate lobes arise from Rathke’s pouch, an invagination
of the oral ectoderm. The posterior lobe arises from an
evagination of neural ectoderm from the ventral diencephalon,
known as the infundibulum. The infundibulum induces the
formation of Rathke’s pouch from the oral ectoderm at
embryonic day 9.0 (E9.0) (Gleiberman et al., 1999). Bmp4 is
expressed in the ventral diencephalon at the contact point
between the neural and oral ectoderm (Ericson et al., 1998;
Treier et al., 1998), suggesting that Bmp4 could induce the
formation of Rathke’s pouch. In fact, Bmp4 homozygous null
embryos fail to form Rathke’s pouch, demonstrating the
requirement of Bmp4 for this induction (Takuma et al., 1998).
Once Rathke’s pouch is induced, it continues to proliferate
and expand. Eventually it will separate from the oral ectoderm
by E11.5. Bmp2 is expressed in the ventral portion of Rathke’s
pouch as well as in the adjacent ventral mesenchyme at E10.5,
just before the pouch separates from the oral ectoderm (Ericson
et al., 1998; Treier et al., 1998). Whether or not Bmp2 maintains
this ventral expression pattern in Rathke’s pouch (Ericson et al.,
1998) or expands to encompass all of Rathke’s pouch by E12.0
is unclear (Treier et al., 1998). The continued expression of
Bmp4 in the infundibulum is also unclear, with one report
showing Bmp4 expression declining by E11.5 (Ericson et al.,
1998) and another showing Bmp4 expression being maintained
at E13.5 (Treier et al., 1998). Ectopic expression of noggin, an
extracellular inhibitor of both Bmp 2 and 4, within Rathke’s
pouch and the oral ectoderm prevents the expansion of the pouch
(Treier et al., 1998). Therefore, BMP signaling is required for the
proliferation and expansion of Rathke’s pouch, regardless of the
precise expression of Bmps in and around the pituitary.
Fgf8 is also expressed in the infundibulum beginning at E9.5
and continues through to E14.5 (Ericson et al., 1998; Treier
et al., 1998). Mouse embryos homozygous null for Titf1 (also
known as T/ebp and Nkx2.1) lose Fgf8 expression specifically
in the ventral diencephalon, which results in a rudimentary
Rathke’s pouch (Takuma et al., 1998). In addition, mouse
embryos homozygous null for Fgfr2, a candidate receptor for
Fgf8 in the pituitary, also develop only a rudimentary Rathke’s
pouch (DeMoerlooze et al., 2000). Both of these genetic defects
result in an increase in apoptosis within the pituitary
primordium, suggesting that Fgf signaling is a survival factor
for Rathke’s pouch (De Moerlooze et al., 2000; Takuma et al.,
1998). Ectopic expression of Fgf8 in the anterior lobe of the
pituitary dramatically increases the size of the anterior lobe,
further supporting a role for Fgf signaling in proliferation of
pituitary cells (Treier et al., 1998).
Once Rathke’s pouch is established, undifferentiated pitui-
tary cells proliferate around the lumen, with the area of most
active proliferation located at the dorsal aspect of the pouch,
presumably in response to signaling from the ventral dience-
phalon (Ikeda and Yoshimoto, 1991). Beginning at E11.5 some
undifferentiated cells become post-mitotic, migrate ventrally
and rostrally away from the lumen into the anterior lobe andbegin to express differentiation markers that signify their cell
type specification (Ward et al., 2005). Bmp and Fgf signaling
also influence the cell specification process. Expression of a
dominant-negative Bmp receptor throughout the anterior lobe
causes a loss of the Pit1 lineage of cell types, including
somatotropes that secrete growth hormone (GH), lactotropes
that secrete prolactin (Prl) and thyrotropes that secrete thyroid
stimulating hormone (TSH) (Treier et al., 1998). Corticotropes,
which secrete adrenocorticotropic hormone (ACTH), and
gonadotropes, which secrete follicle stimulating hormone
(FSH) and luteinizing hormone (LH), are unaffected. Ectopic
expression of Bmp4 throughout the anterior lobe prevents the
terminal differentiation of all cell types of the anterior lobe
except corticotropes. This occurs despite the fact that cell-type-
specific transcription factors are still expressed, indicating that
attenuation of the Bmp signal is probably necessary to allow for
terminal differentiation. Ectopic expression of Fgf8 also
prevents the differentiation of all cell types except corticotropes
and melanotropes, which secrete melanocyte stimulating
hormone (MSH) from the intermediate lobe. Fgf8 inhibits the
expression of cell-type-specific transcription factors including
Pit1, Isl1 and Gata2, indicating that it disrupts differentiation at
an earlier stage than ectopic Bmp expression. These experi-
ments suggest that a ventral to dorsal gradient of Bmp2 in the
anterior lobe interacts with a dorsal to ventral gradient of Fgf8
from the infundibulum to drive cell specification in the anterior
lobe of the pituitary.
This gradient model for pituitary cell specification is
supported by in vitro assays. Explants of infundibulum or
beads soaked in Fgf2 promote the expression of Lhx3 and
ACTH, dorsal markers in the anterior lobe for corticotropes, and
inhibit the expression of Isl1 and αGSU, ventral markers in the
anterior lobe for gonadotropes and thyrotropes (Ericson et al.,
1998). In addition, COS cells expressing Bmp2 promote and
expand Isl1 expression in Rathke’s pouch explants, while
inhibiting the expression of ACTH.
The model for interacting Bmp and Fgf gradients in the
pituitary has been popular for some time, but there is little data
for how those gradients are generated or regulated. A key
component of morphogenetic gradients is the presence of
extracellular proteins that inhibit the activity of the morphogen
(Mizutani et al., 2005). There are at least seven known
extracellular inhibitors of Bmps in vertebrates (Balemans and
Van Hul, 2002). At present there is little information on the
expression of either Bmp or Fgf antagonists in or around the
pituitary. Only the expression of chordin, an antagonist of Bmp
signaling, has been described. It is expressed in the mesenchyme
caudal to Rathke’s pouch, but its role in regulating Bmp sig-
naling within Rathke’s pouch is unknown (Treier et al., 1998).
We hypothesized that Bmp antagonists play an important
role in regulating Bmp signaling during Rathke’s pouch
induction and anterior lobe cell specification. To test this idea,
we examined the expression pattern of other known Bmp
antagonists in and around the pituitary including Nbl1, follis-
tatin-like 1 (Fstl1) and noggin. Noggin is expressed in the
ventral diencephalon in a domain overlapping that of Bmp4 at
E9.5, and then in the underlying cartilage plate by E12.5. Its
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Bmp4 activity, influencing formation of Rathke’s pouch and
later reduce Bmp2 signaling from the ventral mesenchyme
during cell specification. We report that noggin−/− embryos
have pituitary defects that range from a lack of a morphological
Rathke’s pouch to the formation of secondary pituitary tissue.
We show here that noggin attenuates the Bmp4 signal
emanating from the ventral diencephalon during the induction
and early patterning of Rathke’s pouch, but it does not play a
critical role in cell specification in the anterior lobe. The effects
of noggin deficiency on pituitary development are likely to be a
consequence of the imbalance in signaling factors that occurs in
the ventral diencephalon as a result of increased Bmp signaling.
We present a model for the integration of signaling pathways
necessary to establish patterns of gene expression in the ventral
diencephalon that are critical for normal pituitary development.
Materials and methods
Mice
Noggin+/− mice on a C57BL/6 background (Nogtm1Amc), kindly provided by
R. Harland (McMahon et al., 1998), were crossed to 129X1/SvJ mice (Jackson
Laboratories) to create a hybrid line with enhanced breeding characteristics. All
data included here were generated using this hybrid line, except where indicated.
The hybrid line was later crossed to outbred CD-1 mice (Charles River
Laboratories). The same range of phenotypes was observed in the both the
hybrid line and in the outbred line.
Bmpr1a+/− mice (Bmpr1atm1Bhr), kindly provided by Y. Mishina (Mishina
et al., 1995), were crossed to αGSU-cremice (Tg(Cga-cre)Sac3) (Cushman et al.,
2000) to create Bmpr1a+/−;αGSU-cre studs. These studs were crossed to
Bmpr1a fx/fx (Bmpr1atm2.1Bhr) (Mishina et al., 2002) females to generate the
conditionally deleted Bmpr1a null embryos: Bmpr1a fx/−;αGSU-cre.
Histology and gene expression detection
Noggin−/− embryos generated from heterozygous intercrosses were fixed in
3.7% formaldehyde in phosphate-buffered saline (PBS), pH 7.2, overnight at
4 C. After washing, dehydrating and embedding in paraffin, embryos were
sectioned in a sagittal orientation at 6 μm (Hogan et al., 1994). Sections were
stained with hematoxylin and eosin (Hogan et al., 1994).
β-Galatosidase activity from the noggin null allele was detected with X-gal
staining in whole mount (Hogan et al., 1994). Noggin+/− embryos were also
frozen in a dry ice/ethanol bath, and then embedded in O.C.T. Compound
(Electron Microscopy Services). Frozen sections were cut at 16 μm, stained with
X-gal and counterstained with Neutral Red (Hogan et al., 1994).
RNA in situ hybridization was preformed as described previously (Cushman
et al., 2001). Fstl1, Id3 and Six6 cDNAs were isolated from an embryonic
pituitary cDNA library (Carninci et al., 2003) and used to generate antisense
probes. Bmp2 (Lyons et al., 1989), Bmp4 (Jones et al., 1991), Nbl1 (Stanley
et al., 1998) and Fgf10 (Bellusci et al., 1997) in situ hybridizations were
reported previously.
Immunohistochemistry, cell proliferation, cell death
Immunohistochemistry was performed after boiling 10 min in 0.1 M citrate,
pH 6.0, to unmask epitopes and incubation for 20 min at room temperature in
3% H2O2:Methanol 1:1 to inactivate endogenous peroxidases. Antibodies used
were LHX3 and ISL1 (Developmental Studies Hybridoma Bank), SHH (R&D
Systems), TLE3 (Chemicon), PITX1 (kind gift of J. Drouin) and αGSU, POMC,
LH, TSH and GH (National Hormone and Pituitary Program). Species
appropriate biotinylated secondary antibodies were used in conjunction with
streptavidin conjugated horseradish peroxidase (Vectastain MOM for mouse,
and Vector Elite for rabbit and human (Vector Laboratories)). Fluorescein colorreaction was performed with a tyramide signal amplification system
(PerkinElmer LifeSciences). Sections were then counterstained with 4,6-
diamidino-2-phenylindole, dihydrochloride (DAPI, Molecular Probes).
Cell proliferation was assayed as described previously (Ward et al., 2005) by
incorporation of 100 mg BrdU per gram of body weight injected into pregnant
mice 2 h prior to harvesting embryos. BrdU was detected by immunohis-
tochemistry using a rat antibody (Harlan Sera) as above.
Cell death was assayed using an In situ Cell Detection Kit POD (Roche).
Results
Noggin expression suggests a role in regulation of Bmp
signaling
We re-examined the expression patterns for Bmp2 and 4 and
compared them to the expression of a panel of Bmp antagonists
that might regulate the activity of these morphogenetic proteins.
We found that Bmp2 is expressed throughout Rathke’s pouch at
E12.5 and not just in the mesenchyme ventral to Rathke’s pouch
(Fig. 1A; Ericson et al., 1998; Treier et al., 1998). Bmp4
expression continues in the infundibulum after E11.5 until at
least E14.5 (Fig. 1B). Three antagonists, Fstl1, Nbl1 (Dan) and
noggin had spatial–temporal expression patterns that imply a
possible role for these proteins during pituitary development.
Nbl1 begins its expression in the mesenchyme caudal to
Rathke’s pouch at E12.5 and increases in intensity by E14.5,
expanding to encompass all of the mesenchyme surrounding the
pituitary (Figs. 1C, D). Fstl1 begins its expression in the
infundibulum at E12.5 (Fig. 1E). Fstl1 is also expressed in the
mesenchyme surrounding the pituitary at E14.5, and it is
strongly expressed in the infundibulum and intermediate lobe
(Fig. 1F).
Noggin is expressed in the ventral diencephalon at E9.5 and
10.5 (Figs. 1G–I) and then in the cartilage plate underlying the
pituitary beginning at E12.5 and continuing through embryonic
development (Figs. 1J, K). No expression was detected in
Rathke’s pouch at E9.5 or the pituitary anterior lobe at E10.5,
12.5 or E17.5. At weaning, noggin expression is detected in the
anterior lobe (data not shown) where it continues its expression
into adulthood (Fig. 1L). The noggin expression in the ventral
diencephalon is coincident with the expression of Bmp4 (Fig. 1I
inset), suggesting that in the absence of noggin, excess Bmp4
could emanate from the ventral diencephalon. Bmp2 is
expressed in Rathke’s pouch and the adjacent ventral
mesenchyme beginning at E10.5 (Ericson et al., 1998; Treier
et al., 1998). The expression of noggin in the cartilage plate
adjacent to this ventral expression of Bmp2 could attenuate this
signal.
Noggin is a more potent inhibitor of Bmp 2 and 4 than
Nbl1 (Balemans and Van Hul, 2002). Nbl1 null mice also
show no observable defects (Dionne et al., 2001). Fstl1 is
assumed to inhibit Bmp and Activin based on its homology to
follistatin (Balemans and Van Hul, 2002), but its biochemical
interactions have not been demonstrated. Because noggin is a
known, potent inhibitor of Bmp2 and 4 and because noggin
null embryos have an observable embryonic phenotype, we
chose to continue our analysis of noggin function in pituitary
development.
Fig. 1. Pituitary expression patterns of Bmps and Bmp antagonists. (A–F) RNA in situ hybridization on wild-type embryos. (A) Bmp2 at E12.5. (B) Bmp4 at E14.5.
(C) Nbl1 at E12.5. (D) Nbl1 at E14.5. (E) Fstl1 at E12.5. (F) Fstl1 at E14.5. (G–L) Nog+/− embryos stained with X-gal for β-galactosidase activity. (G) An E9.5
embryo where the pharyngeal arches were removed to visualize the oral ectoderm. The arrow indicates expression in the ventral diencephalon. (H–J) Midsagittal
sections counterstained with neural red. (H) An E9.5 embryo where the arrow indicates expression in the ventral diencephalon, while the arrowhead indicates Rathke's
pouch, which lacks expression. (I) An E10.5 embryo with Nog expression in the ventral diencephalon. Inset shows Bmp4 expression in the same region of the ventral
diencephalon. (J) An E12.5 embryo where the arrow indicates expression in the forming cartilage plate. (K) An E17.5 embryo where strong expression is seen in the
cartilage plate, but no expression in the anterior pituitary (arrowhead). (L) Pituitary from an adult mouse. Strong expression is seen in the anterior lobe (a) compared to
no expression in the posterior lobe (p). Scale bars equal 400 μm.
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We examined noggin−/− embryos (McMahon et al., 1998)
for a pituitary phenotype in order to determine if noggin
regulates either the induction of Rathke’s pouch by Bmp4, or
cell specification by Bmp2. Noggin−/− embryos can have
severe neural tube defects including exencephaly and spina
bifida (McMahon et al., 1998). However, our observations
suggest that contact between the ventral diencephalon and the
oral ectoderm is typically maintained in noggin−/− embryos at
E9.5 and 10.5 when Rathke’s pouch induction occurs.
Therefore, any defects in the pituitary resulting from a loss
of noggin are probably not secondary to a broader forebrain
defect.
We grouped noggin−/− embryos into an early pituitary
development cohort (E11.5–14.5) and a late pituitary develop-
ment cohort (E15.5–18.5). Noggin−/− mice have a variable
pituitary phenotype (Fig. 2 and Table 1) that includes an
absence of a morphologically identifiable pituitary, an apparent
secondary Rathke’s pouch or anterior lobe and rostral
displacement of Rathke’s pouch at both the early and late
time points. The difference observed between the two timepoints is a decrease in the percentage of embryos with
secondary pituitary tissue at the later stages.
At E10.5 Rathke’s pouch is severely malformed (Figs. 2E, I,
M). Multiple invaginations occur within the oral ectoderm
(Figs. 2E, I), especially toward the rostral side of Rathke’s
pouch where it is in close proximity to the ventral
diencephalon. When only one invagination is observed,
Rathke’s pouch appears enlarged and extends further rostrally
compared to wild-type embryos (Fig. 2M). Some individuals
had no obvious pituitary tissue, and the cleft between the
midbrain and hindbrain where the pituitary normally forms was
filled with mesenchyme (Figs. 2F–H). In embryos that have
duplications of Rathke’s pouch the location of the two
invaginations can be widely spaced (Fig. 2J) or arise adjacent
to each other (Fig. 2K). By E16.5, the pituitary duplication can
be very prominent (Fig. 2L). In the most frequent phenotype,
rostral displacement, Rathke’s pouch is elongated and extends
more rostrally than in wild-type embryos (2 N). This elongated
morphology can be maintained until later stages of develop-
ment (Figs. 2O, P), including maintaining a connection with the
oral ectoderm (Fig. 2O). Eventually, the cartilage plate, which
usually lies beneath the pituitary, can surround the mutant
Fig. 2. Phenotypic variability in nog−/− embryos. (A–D) Wild-type embryos at E10.5, 12.5, 13.5 and 16.5, respectively. Yellow dotted line indicates Rathke's pouch
and the anterior lobe. (E–P) Nog−/− embryos at (E, I, M) E10.5, (F, J, N) E12.5, (G, K, O) E13.5, (H) E15.5, (L and P) E16.5. A morphological pituitary is not visible in
panels F, G or H. Arrowheads in panels J–L indicate secondary pituitary tissue. Arrowhead in panel P indicates Rathke's pouch displaced more rostrally. Scale bars
equal 400 μm.
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(Fig. 2P).
The ventral diencephalon of mutants has morphological
abnormalities. The characteristic indention of the forming
infundibulum at E10.5 (Fig. 2A) is not observed in noggin−/−
embryos (Figs. 2E, I, M). The characteristic thickening of the
neuroepithelium in the ventral diencephalon just rostral toTable 1
Phenotypes observed in Nog−/− embryos at early and late stages of pituitary
development
Phenotype Developmental stage a
E11.5–14.5 E15.5–18.5
No Rathke's pouch 3 (14%) 3 (21%)
Rostral displacement 10 (48%) 8 (57%)
Secondary tissue 6 (29%) 2 (14%)
Normal location 2 (10%) 1 (7%)
Total number of embryos 21 14
a The number of embryos observed for each phenotype is listed with the
percentage of the total included in parentheses.Rathke’s pouch is (Fig. 2B) decreased or absent in noggin−/−
embryos (Figs. 2F, J, N). A morphologically distinct infundi-
bulum is frequently absent in noggin−/− embryos. Of the nine
noggin−/− embryos examined between E12.5 and 16.5 that are
presented in Fig. 2, only two (Figs. 2K, L) have an obvious
infundibulum.
Despite the fact that 14% of noggin−/− embryos do not have
an observable Rathke’s pouch, two early markers of pituitary
development, Pitx1 (Figs. 3A, B) and Isl1 (Figs. 3C, D), are
clearly expressed at E12.5. This indicates that Rathke’s pouch is
induced, in terms of transcriptional activation of pituitary
markers, but lacks the proper morphology. The domain of
expression for these markers is also displaced rostrally, similar
to the rostral displacement of pituitary tissue observed in the
majority of mutant embryos. To determine if pituitary cell
specification occurs in these embryos, an E15.5 embryo lacking
a morphological pituitary was examined for the presence of the
hormones αGSU (alpha subunit of the glycoprotein hormones
TSH, LH, and FSH, also known as Cga) (Figs. 3E, F) and pro-
opio-melanocortin (POMC) (Figs. 3G, H). POMC is proteoly-
Fig. 3. Pituitary tissue forms in embryos without a morphologically identifiable pituitary. (A–D) E12.5 mid-sagittal sections. (E–H) E15.5 mid-sagittal sections. (A, C,
E, and G) Wild-type embryos. (B, D, F, and H) Nog−/− embryos. (A, B) Pitx1 immunohistochemistry. (C, D) Isl1 immunohistochemistry. (E, F) αGSU
immunohistochemistry. (G, H) ACTH immunohistochemistry. All sections counterstained with DAPI. Scale bar equals 400 μm for all images.
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MSH and β-endorphin in the intermediate lobe. The embryo
examined had a severe neural tube defect that altered its gross
head morphology, splitting the embryo down the anterior
midline (Fig. 3H, inset). Both αGSU and POMC were
expressed in a small domain located near the rostral end of
the embryo, despite the severe disruptions in morphology,
indicating that cell specification can occur in these embryos.
We extended the cell specification and terminal differentia-
tion analysis to both primary and secondary pituitary tissue at
E17.5 and 18.5 using molecular markers of the anterior and
intermediate lobes. Secondary pituitary tissue expresses Pitx1 at
E17.5 confirming that this structure is specified as pituitary
tissue (Figs. 4A, G). However, the hormones GH, LH, TSH and
POMC are not expressed in the secondary tissue (Figs. 4H–K).
All of these hormones are detected in the primary anterior lobe
of mutant embryos, indicating that cell specification is
occurring in portions of the pituitary tissue in the absence of
noggin. Given the variable phenotype of noggin mutant
embryos, we examined additional representative mutant
embryos at E18.5 (Figs. 4M–X). Noggin mutant embryos
expressed all of the hormones examined, but at variable levels.
We conclude that noggin is not required for cell specification,
but it can affect the number of terminally differentiated cells
produced. Prolactin expression was not detectable at these time
points; therefore, we cannot rule out an affect of noggin on cell
specification of lactotropes. At no time did we observe pre-
cocious expression of the hormones examined (data not shown).
Occasionally, we observed a more pronounced effect on the
expression of Tle3, a marker of the prospective intermediate
lobe (Fig. 4F). In two out of five embryos examined at E16.5 to
18.5, Tle3 was absent from the intermediate lobe (Fig. 4R). The
loss of Tle3 in the intermediate lobe may be responsible for the
decrease in POMC expression that was also observed in these
same embryos (Fig. 4Q).Bmp signaling is enhanced in the absence of noggin
The morphology of Rathke’s pouch in noggin mutants at
E10.5 suggests that multiple invaginations of the oral
ectoderm may occur in response to increased BMP4 activity.
To determine whether all of the invaginations had a Rathke’s
pouch identity, we carried out immunohistochemistry using
the early transcription factor markers for Rathke’s pouch,
Pitx1, Isl1 and Lhx3. Both Pitx1 (Figs. 5A, B) and Isl1 (Figs.
5D, E) are expressed throughout the multiple invaginations.
Lhx3, however, was not expressed at E10.5 in mutant
embryos (Figs. 5G, H). Explant experiments have shown that
Lhx3 is expressed in response to FGF signals from the
infundibulum (Ericson et al., 1998); therefore, increased
BMP4 activity in the ventral diencephalon may be antag-
onizing FGF signaling resulting in repression of Lhx3. In
noggin−/− embryos at E16.5, Isl1 is still expressed in both the
wild-type and noggin−/− embryos (Figs. 5J, K). Expression
of Lhx3 recovers at this time in the mutant embryos,
suggesting that there are different requirements for initiation
of Lhx3 transcription at different developmental times. This
phenomena is also observed in Lhx4−/− mice (Raetzman et
al., 2002).
Bmpr1a is critical for Bmp signaling
Bmp4 null embryos fail to form Rathke’s pouch, preventing
an examination of Bmp signaling in Rathke’s pouch following
this initial induction (Takuma et al., 1998). In order to
investigate the role of Bmp signaling in the early formation of
Rathke’s pouch, we used a conditional allele of Bmpr1a
(Mishina et al., 2002) in combination with a cre recombinase
driven by αGSU (Cushman et al., 2000), which begins
expression in Rathke’s pouch at E9.5 after the initial induction
of the pouch. This αGSU-cre transgene is effective for deletion
Fig. 4. Cell specification detected in nog−/− pituitaries using immunohistochemistry for cell-type-specific hormones and transcription factors. All images are E17.5 or
18.5 mid-sagittal sections. (A–F) Wild-type E18.5 embryos. (G–L) Nog−/− E17.5 embryos. (M–X) Nog−/− E18.5 embryos. (A, G, M and S) Pitx1. (B, H, N and T)
GH. (C, I, O and U) LH. (D, J, P and V) TSH. (E, K, Q and W) POMC. (F, L, R and X) Tle3. (G) 1 indicates primary pituitary, 2 indicates secondary pituitary tissue.
(H–K) Note the absence of terminal differentiation in the secondary pituitary. All images counterstained with DAPI. Scale bar equals 400 μm for all images.
151S.W. Davis, S.A. Camper / Developmental Biology 305 (2007) 145–160between loxP sites in the pituitary gland (Zhao et al., 2001);
however, it exhibits ectopic cre activity in the heart and muscle
(Cushman et al., 2000).We analyzed Rathke’s pouch patterning in αGSU-cre;
Bmpr1afx/− embryos at E10.5. The pouch is thin and under-
developed compared to wild-type littermates (Figs. 5C, F, I).
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153S.W. Davis, S.A. Camper / Developmental Biology 305 (2007) 145–160Some commitment to pituitary organogenesis is evident by the
expression of Pitx1 and Lhx3 (Figs. 5C, I); however, Isl1
expression is absent (Fig. 5F). Explant studies suggest that Bmp
signaling induces Isl1 in the ventral aspect of the pituitary
(Ericson et al., 1998). Therefore, Bmp induction of Isl1 in
Rathke’s pouch is dependent on Bmpr1a. Pituitary analysis at
later time points is not possible because embryonic lethality
occurs at E12.5. αGSU-cre;Bmpr1a fx/− embryos are smaller in
size than wild-type littermates and have heart defects, which is
the probable cause of death (data not shown).
Loss of noggin alters patterns of cell death
Bmp4 activity is necessary for the induction of Rathke’s
pouch and cell proliferation within the pouch (Takuma et al.,
1998). An increased level of Bmp4 activity could cause an
increase in proliferation. We injected pregnant mice with
bromo-deoxyuridine (BrdU) 2 h before harvesting E10.5
embryos in order to label actively dividing cells. BrdU
incorporation was detected by immunohistochemistry. Prolifer-
ating cells in the ventral diencephalon are detected both rostral
and caudal to the forming infundibulum in wild-type embryos,
but they are infrequently observed in the infundibulum itself at
E10.5 (Fig. 6A). Proliferating cells are uniformly distributed
throughout Rathke’s pouch. We examined three noggin−/−
embryos and observed variable results. Two embryos had an
equal or greater percentage of proliferating cells in the ventral
diencephalon relative to wild-type (Fig. 6B, Table 2). This trend
was also true for cells in Rathke’s pouch where considerable
variability was also observed (Table 2). This variability in
proliferation is not unexpected given the variable morphology
and size of noggin−/− pituitaries.
A small zone of cell death is normally located on the ventral
side of Rathke’s pouch and may be important for the separation
of Rathke’s pouch from the oral ectoderm (arrowhead in Fig.
6D). Because the noggin−/− embryos appear to have a delay in
pinching off Rathke’s pouch (Fig. 2J), we used TUNEL analysis
to examine apoptosis and found that this domain is absent in
noggin−/− embryos at E10.5, but already detectable in wild-type
littermates (Figs. 6E, F). Some noggin−/− embryos are able to
undergo separation of Rathke’s pouch from the oral ectoderm
(Fig. 2K); therefore, we investigated whether there is a delay in
apoptosis in noggin−/− embryos. At E11.5 wild-type embryos
still have apoptotic domains at the contact points between
Rathke’s pouch and the oral ectoderm (Fig. 6G). However, this
apoptotic domain was not observed in E11.5 noggin−/− embryos
(Figs. 6H, I). Apoptotic cells are observed in the secondary
invaginations of oral ectoderm of noggin−/− embryos (arrow-
heads Figs. 6H, I), where lower levels of Pitx1 expression are
observed (Figs. 6K, L). This suggests that these secondary
invaginations lack important survival factors, which could
account for the decrease in secondary pituitary tissue in later
stages of pituitary development. By E12.5, Rathke’s pouch is
fully separated from the oral ectoderm in wild-type embryos and
cell death is not detectable within Rathke’s pouch (Fig. 6M).
Cell death is absent in noggin−/− embryos that fail to undergo
separation of Rathke’s pouch (Fig. 6N). Apoptotic cells areevident in mildly affected embryos in a small domain at the
contact point between the oral ectoderm and Rathke’s pouch
(Fig. 6O).
Apoptosis is not observed in the ventral diencephalon in
wild-type embryos (Fig. 6C). Noggin−/− embryos do have a
significant domain of cell death in the ventral diencephalon
(arrowhead in Fig. 6D), suggesting that increased Bmp4 activity
could promote apoptosis within this domain.
Loss of noggin expands Bmp activity in the ventral
diencephalon
Because Noggin and Bmp4 interact extracellularly, no
change in Bmp4 transcription in the ventral diencephalon of
noggin mutants is expected. We confirmed this by examining
three noggin−/− embryos for Bmp4 expression in the ventral
diencephalon by in situ hybridization. There were no apparent
differences in the signals observed in wild-type and noggin−/−
embryos, suggesting that Bmp4 transcription is not affected by
the loss of noggin (data not shown).
We used two different techniques to determine whether Bmp
signaling is increased in the absence of noggin. Id3 is an
immediate response gene for Bmp signaling (Hollnagel et al.,
1999), that had been uncharacterized in the developing pituitary
gland. We determined that Id3 is normally expressed at low
levels in the ventral diencephalon and Rathke’s pouch at E10.5
(Fig. 7A). In noggin−/− embryos, Id3 is upregulated in the
ventral diencephalon, indicating an increase in Bmp activity
(Fig. 7B). We also assessed Bmp activity using immunohisto-
chemical staining specific for the phosphorylated form of
Smad1 (pSmad1), an intracellular signaling component of the
Bmp pathway (Fig. 7C). Smad1 is phosphorylated in the
forming infundibulum of wild-type embryos where Bmp4 is
expressed and in scattered cells within the ventral diencephalon
domain rostral to the infundibulum (bracket Fig. 7C). Also,
pSmad1 immunoreactivity is detected in the ventral half of
Rathke’s pouch, where expression of Bmp2 initiates, and
immunoreactivity tapers off toward the dorsal side of the pouch
(Fig. 7C). Noggin mutants exhibit increased pSmad1 staining at
E10.5 in both the ventral diencephalon (bracket Fig. 7D) and in
the dorsal domain of Rathke’s pouch, confirming that noggin
normally inhibits Bmp signaling (Fig. 7D).
To examine the effect of increased Bmp signaling on ventral
diencephalon patterning, we performed in situ hybridization for
Fgf10 and Six6, which mark adjacent domains within the
ventral diencephalon (Figs. 7E, G). Six6 is expressed in the
ventral diencephalon and within Rathke’s pouch beginning at
E10.5, where it is necessary for regulating proliferation within
pituitary precursor cells (Jean et al., 1999; Li et al., 2002).
Fgf10 is normally expressed in an overlapping pattern with
Bmp4 and noggin. In the absence of noggin, Fgf10 expression
is reduced and shifted rostrally (Fig. 7F). This could explain the
lack of Lhx3 expression in noggin−/− embryos and the loss of
secondary invaginations through apoptosis. Six6 marks a
domain immediately rostral to the Bmp4 expression domain
(Fig. 7G). In the absence of noggin, Six6 expression is also
reduced and shifted rostrally (Fig. 7H). The wild-type domain
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Table 2
Quantitation of proliferating cells a
Region Wild type Nog−/−
Ventral diencephalon
BrdU-positive cells 18 14 27 8 23
Total cells 45 40 60 34 33
Percent 40 35 45 23 69
Rathke’s pouch
BrdU 80 57 14 36 29
Total cells 111 77 51 57 53
Percent 72 74 27 63 55
a Data are tabulated for two wild-type and three noggin−/− embryos.
155S.W. Davis, S.A. Camper / Developmental Biology 305 (2007) 145–160of Six6 expression in the ventral diencephalon is also marked by
Shh (Fig. 7I). In noggin−/− embryos Shh is still expressed in this
domain (Fig. 7J), although the domain appears to be decreased
in size. Together this data suggests that the effective domain of
Bmp activity has been expanded in the ventral diencephalon of
the mutants. This expanded domain can therefore induce a
broader region of oral ectoderm to become Rathke’s pouch,
producing the secondary pituitary tissue observed in some
noggin−/− embryos. These results highlight the complex
regulation of signaling molecules and their inhibitors that are
necessary for normal pituitary organogenesis.
Discussion
Ectopic expression of noggin in Rathke’s pouch and the oral
ectoderm prevents expansion and proliferation of the pouch
(Treier et al., 1998). Loss of Bmp4 expression results in failure
of Rathke’s pouch induction (Takuma et al., 1998). Together
these observations provide convincing proof that Bmp signaling
is required for the formation of Rathke’s pouch. In a corollary
experiment, Bmp4 expression was driven in the anterior lobe by
a transgene prior to cell type determination, and it prevented
terminal differentiation (Treier et al., 1998). While these
transgenic experiments provide the basis for the current model
for Bmp signaling in pituitary gland development, many
questions remain regarding the in vivo role for Bmps and their
inhibitors.
This report enhances our understanding of the endogenous
roles of Bmp4 and noggin during pituitary development. We
show that noggin is critical for modulating the inductive activity
of Bmp4 in the formation of Rathke’s pouch. Removing this
inhibitor of Bmp signaling causes an expansion of the effective
area of Bmp4 activity (Fig. 8), which disrupts the patterning of
the ventral diencephalon. Noggin deficiency causes a rostral
shift in the boundary between the Bmp4 expressing region (the
upper domain) and the Shh expressing region (the lower
domain) of the ventral diencephalon. Expanded Bmp signaling
likely accounts for both the rostral shift in location of Rathke’s
pouch and the formation of multiple invaginations of oral
ectoderm. The pituitary tissue produced by excessive Bmp
activity is varied. The spectrum includes no morphologically
discernible Rathke’s pouch, a rostrally displaced Rathke’s
pouch, and formation of secondary pituitary tissue that is
arrested in cell specification and likely lost through apoptosis.Bmp and Bmp inhibitor expression suggest additional roles in
pituitary development
The current models of pituitary development are built on
expression data for Bmp 2 and 4 that are not consistent in the
literature. In all reports, Bmp4 is expressed in the ventral
diencephalon and infundibulum; however, the timing of Bmp4
downregulation in the infundibulum is unclear. Our results
indicate that Bmp4 is not downregulated at E11.0 but continues
its expression at E14.5. The current model for anterior pituitary
cell specification after E10.5 relies on an intrinsic program of
signaling within Rathke’s pouch (Treier et al., 1998). However,
both Fgf10 and Bmp4 are expressed in the infundibulum after
E11.5 and could continue to influence pituitary development.
While noggin−/− embryos can undergo anterior and intermedi-
ate lobe cell specification, the number of terminally differ-
entiated cells is reduced or lost in a portion of the mutant
embryos.
Bmp2 is expressed in the mesenchyme adjacent to Rathke’s
pouch at E10.5–E12.5, but previous reports are not clear as to
whether Bmp2 is expressed within Rathke’s pouch. Our results
indicate that Bmp2 is expressed throughout Rathke’s pouch at
E12.5, in addition to the expression in the adjacent ventral
mesenchyme. The current model of cell specification describes
a ventral to dorsal gradient of Bmp signaling that antagonizes a
dorsal to ventral gradient of Fgf signaling. While such a
gradient may exist at E10.5 when Bmp2 is restricted to the
ventral portion of Rathke’s pouch, it is difficult to imagine a
gradient of Bmp2 activity at E12.5 when it is expressed
throughout the pouch.
The presence of Bmp inhibitors could establish and maintain
a ventral gradient of Bmp signaling within Rathke’s pouch even
as Bmp2 expands to the dorsal side. Prior to this report, chordin
was the only Bmp antagonist known to be expressed near the
pituitary (Treier et al., 1998). We show spatial and temporal
expression of three different Bmp antagonists, which reveals the
potential complexity of regulation of Bmp signaling. Nbl1 is
expressed in the mesenchyme surrounding the entire pituitary,
and Fstl1 is expressed in the mesenchyme, infundibulum, and
intermediate lobe. The expression of Fstl1 suggests that it could
regulate Bmp signaling within the anterior lobe, especially on
the dorsal side. It will be interesting to assess the functional role
of this and other Bmp antagonists within the developing
pituitary.
Noggin deficiency causes severe morphological disruptions in
pituitary development
The spatial and temporal expression pattern of noggin in the
ventral diencephalon implies that noggin could regulate the
induction of Rathke’s pouch. Our analysis demonstrates that
noggin is critical for regulating the size and location of
Rathke’s pouch. In the absence of noggin, there is an expanded
domain of Bmp activity that results in a rostral shift in location
of the oral ectoderm invagination and the production of
secondary invaginations. Variable outcomes result from this
variable field of induced pituitary tissue. The variability in
Fig. 7. Increased Bmp signaling in the ventral diencephalon disrupts ventral diencephalon patterning. All images are from E10.5 mid-sagittal sections. (A, C, E, G and I)
Wild-type, (B, D, F, H, and J) Nog−/− (A, B) Id3 in situ hybridization. Compare bracketed region in panels B to A. (C, D) Anti-phosphorylated Smad1
immunohistochemistry, counterstained with DAPI. Compare bracketed region in panels D to C. Boxed-in region in panels C and D shown at higher magnification in
panels C′ and D′ (E, F) Fgf10 in situ hybridization. (G, H) Six6 in situ hybridization. (I, J) Shh immunohistochemistry, counterstained with DAPI. All paired in situ
hybridizations were developed equally. Scale bar in J equal 400 μm for all images except C′ and D′ where the scale bars equal 400 μm.
156 S.W. Davis, S.A. Camper / Developmental Biology 305 (2007) 145–160phenotypes of noggin-deficient mutants is not unique to the
pituitary. Genetic background effects produce different pheno-
types for noggin−/− embryos. Exencephaly occurs on the C57B/
6J background, and not on 129X1/SvJ; (McMahon et al., 1998).
Background effects suggest that modifying genes influence
Bmp signaling in the absence of noggin. Phenotypic variability
has been described in other tissues when one or more inhibitors
of Bmp are lost. Embryos of the complex genotype noggin+/−;
chordin−/− have a range of anterior defects from anencephaly to
cleft palate (Anderson et al., 2002). Hesx1 deficiency also
causes a range of pituitary and midline phenotypes. The most
severely affected class of Hesx1−/− embryos lack both aninfundibulum and Rathke’s pouch, while the less severely
affected have multiple branches of the lumen of Rathke’ pouch
(Dattani et al., 1998). Therefore, there are many precedents for
the characteristic variability in pituitary development of
noggin−/− embryos.
The expression of noggin in the cartilage plate underlying
the pituitary does not appear to be important for pituitary cell
specification. However, the expression of noggin in the
cartilage is consistent with the role noggin plays in bone
formation. In the absence of noggin the cartilage plate
exhibits hypertrophy similar to that observed in the digits
(Brunet et al., 1998).
Fig. 8. Model for how Noggin regulates Bmp4 during Rathke's pouch induction.
In wild-type embryos Noggin attenuates Bmp4 in the upper domain of the
ventral diencephalon (blue). Bmp4 inhibits Fgf10, also in the upper domain and
establishes a boundary with the Shh and Six6 expressing lower domain (red).
Bmp4 also induces Rathke's pouch from the oral ectoderm. In noggin−/−
embryos, the attenuation of Bmp4 is lost, increasing the effective amount of
Bmp4. An increased amount of Bmp4 inhibits Fgf10 within the upper domain
and shifts the boundary with the lower domain more rostrally. The increased
amount of Bmp4 also causes multiple invaginations of the oral ectoderm.
157S.W. Davis, S.A. Camper / Developmental Biology 305 (2007) 145–160The expression of noggin in the pituitary anterior lobe from
weaning to adulthood is intriguing. A differential screen
between prolactinomas and normal pituitary tissue showed
that noggin is downregulated in the prolactinomas (Paez-Pereda
et al., 2003). Further studies implicated upregulation of Bmp4
as a potential cause for prolactinoma formation (Paez-Pereda
et al., 2003). Therefore, noggin may play a protective role
against prolactinoma formation in adult pituitaries by inhibiting
Bmp signaling. The embryonic lethality of noggin−/− embryos
necessitates the development of a conditional allele of noggin to
study noggin function in adult pituitaries and assess is potential
contribution to this extremely common pituitary adenoma (Asa,
1998).
Ventral diencephalon patterning is disrupted by noggin deficiency
Noggin is not expressed in Rathke’s pouch; therefore, the
variability seen in Rathke’s pouch of noggin-deficient embryos
is not due to a direct effect of noggin action in the pouch.Noggin
deficiency has an indirect effect on the responsiveness of the oral
ectoderm to inductive influence of the ventral diencephalon.
Gene expression analyses reveal a boundary in the ventral
diencephalon just rostral to the infundibulum that separates the
inductive domain from the remaining ventral diencephalon. Shh
and Six6 are expressed rostral to the boundary. Bmp4 and Fgf10
are expressed caudal and dorsal to the boundary, within the
upper domain. Noggin-deficient mice exhibit expansion of Bmp
signaling in the ventral diencephalon, as evidenced by an
expanded area of Id3 expression and phosphorylated Smad1.
This alters the patterning of the ventral diencephalon such that
the upper domain expands rostrally, compromising the adjacent
lower domain by reducing the expression of Shh and Six6. This
increased Bmp signaling also results in a decrease in expression
of Fgf10 within the upper domain.
Based on these data, we propose a model where the ultimate
effect of noggin deficiency on pituitary development isenlargement and rostral shift of the inductive upper domain.
This effect likely causes additional oral ectoderm to be recruited
to form pituitary tissue. The ability of this additional tissue to
form a properly patterned pituitary appears to depend on its
placement in relation to the other structures in the developing
head. If the pituitary is induced more rostrally than normal, then
the pituitary tissue may fail to develop a proper Rathke’s pouch
or fail to progress to form a proper anterior lobe. If secondary
pituitary tissue is induced more caudally, then access to survival
factors, such as Fgf10, is restricted, leading to cell death, tissue
loss and failed cell specification. Terminal differentiation may
not occur in residual secondary pituitary tissue due to restricted
access to the ventral diencephalon and factors it produces.
Cell death domains are lost in Rathke’s pouch and gained in
the ventral diencephalon
The embryonic pituitary has a low level of apoptotic activity
during normal development. This low level of activity is
generally confined to the point where Rathke’s pouch will
separate from the oral ectoderm (Charles et al., 2005). Genetic
mutations that cause a loss or reduction of Rathke’s pouch can
show an increase in apoptosis within the pouch. Fgfr2 IIIb−/−
(De Moerlooze et al., 2000), Lhx4−/−;Prop1−/− (Raetzman et
al., 2002), Pitx2−/− (Charles et al., 2005) and Titf1−/− (Takuma
et al., 1998) embryos all exhibit an increase in apoptosis that
directly contributes to the loss or reduction of Rathke’s pouch.
Unlike these mice, noggin−/− mice show a decrease in apoptosis
that could prevent the separation of Rathke’s Pouch from the
oral ectoderm. In fact, the closure of Rathke’s pouch is often
delayed in noggin mutants, resulting in prolonged connection
with the oral ectoderm. However, when separation does occur,
apoptosis is observed at the contact point between the pouch
and the oral ectoderm. This result supports the idea that
apoptosis is necessary for Rathke’s pouch to separate from the
oral ectoderm.
The presence of apoptotic cells within secondary invagina-
tions of oral ectoderm of noggin−/− embryos at E11.5
suggests that these secondary invaginations lack access to a
critical survival factor, perhaps Fgf10. The downregulation of
Pitx1 expression within these secondary invaginations sup-
ports the idea that this tissue is losing its pituitary identity.
The loss of these invaginations through apoptosis may occur
because the invaginating tissue is not close enough to the
ventral diencephalon to survive and continue to develop. The
downregulation of Fgf10 in noggin mutants may enhance
this effect by removing a key survival factor for Rathke’s
pouch.
While noggin deficiency causes reduced apoptosis in
Rathke’s pouch, a new region of apoptosis forms in the
upper domain of the ventral diencephalon. This region does
not encompass the entire upper domain, and we are unaware
of any ventral diencephalon markers that might identify the
cell types that are lost. Apoptosis may affect the evagination
of the ventral diencephalon to form the infundibulum, as a
well-formed infundibulum is rarely seen in noggin mutant
embryos.
158 S.W. Davis, S.A. Camper / Developmental Biology 305 (2007) 145–160Gain or loss of Bmp signaling in Rathke’s pouch disrupts
pattern formation
Noggin−/− embryos exhibit reduced Lhx3 expression,
probably as a result of the decrease in Fgf10 from the ventral
diencephalon (Fig. 5H). Lhx3 expression appears to be Fgf-
independent at later stages as Lhx3 is expressed by E16.5 in
noggin−/− embryos (Fig. 5J). The recovery of Lhx3 expression
later in development also occurs in Lhx4−/− embryos and may
be sufficient to drive cell specification at these later embryonic
stages.
Isl1 expression in Rathke’s pouch is regulated by Bmp
signaling. Explant studies of Rathke’s pouch demonstrated that
Bmp2 increases Isl1 expression in this tissue (Ericson et al.,
1998), while transgenic expression of Bmp4 in the anterior lobe
of the pituitary expands the domain of Isl1 within the anterior
lobe (Treier et al., 1998). Wild-type and noggin−/− embryos
express Isl1 throughout Rathke’s pouch. However, noggin
mutants occasionally express Isl1 ectopically in the mesench-
yme adjacent to Rathke’s pouch. These ectopic Isl1 cells could
represent a secondary field of pituitary tissue, similar to the area
expressing pituitary markers in noggin mutants without a
morphological Rathke’s pouch.
In contrast to the noggin−/− embryos, Isl1 expression is lost
in Rathke’s pouch of Bmpr1a fx/−;αGSU-cre embryos. By
E10.5, Isl1 is downregulated in the dorsal domain of Rathke’s
pouch, despite the continued expression of Bmp4. Loss of
Bmpr1a within the pouch, therefore, prevents the expression of
Isl1, demonstrating that Bmpr1a is necessary for expression of
this gene. Bmpr1b is also expressed in Rathke’s pouch by E9.5
(Yoshikawa et al., 2000); however, it is not able to compensate
for the loss of Bmpr1a. Perhaps Bmpr1b is necessary for
stimulating additional arms of the Bmp signaling cascade, such
as Map kinase signaling. The expansion of Isl1 expression in
noggin mutant embryos and the reduction of Isl1 expression
in Bmpr1a fx/−;αGSU-cre embryos provide important evidence
in intact animals that confirm the transgenic and in vitro data
that suggests regulation of Isl1 expression by Bmp signaling.
Noggin deficiency does not alter cell specification in the
anterior lobe
Cell specification in the anterior lobe can occur in the absence
of noggin, as some noggin−/− embryos develop the full range of
cell types in the anterior lobe. Noggin is instrumental for the
correct size and position of the pituitary. Once the size and
location of the pituitary is determined; however, cell specifica-
tion occurs independent of noggin expression. In contrast,
pituitary tissue developing more rostrally or caudally than ap-
propriate fails to differentiate fully, presumably because it is too
distant from the signaling centers of the ventral diencephalon.
The specification of the intermediate lobe is variably affected
by the loss of noggin. Tle3 and POMC expression is variably
reduced in the absence of noggin. Bmp signaling represses
transcription of POMC (Nudi et al., 2005). An increase in Bmp
activity in the infundibulum may represses POMC and Tle3 as
well. The role of Tle3 in pituitary gland development is not wellestablished. Tle3 may act as a co-repressor with engrailed
homology domain containing transcription factors to prevent
the differentiation of proliferating cells around the lumen
(Brinkmeier et al., 2003), or it may act positively to regulate the
differentiation of melanotropes in the intermediate lobe.
Models of pituitary duplications
The pituitary duplication that we report for noggin mutant
embryos has not been noted in other mouse models; however,
there are other mutations that lead to an expansion of Rathke’s
Pouch. Tcf4−/− embryos have an enlarged anterior lobe, which
appears to result from the recruitment of additional oral
ectoderm into Rathke’s pouch (Brinkmeier et al., 2003). Rx−/−
embryos do not form a traditional pituitary, but instead a large
field of oral ectoderm is transformed into pituitary hormone
producing cells that line the roof of the mouth, suggesting that
additional tissue has been recruited to form pituitary tissue
(personal communication E.A. Kozhemyakina and P.H. Mathers
of West Virginia University).
Pituitary duplication occurs very rarely in humans (Kollias
et al., 1995). The anterior, intermediate and posterior lobes and
the pituitary stalk are all duplicated. Patients with duplicated
pituitaries also exhibit additional midline defects including cleft
palate and basilar artery duplication. The cause for the
duplication is often attributed to a split at the rostral end of
the notochord causing a local duplication of midline structures
(Kollias et al., 1995). Supporting the idea that excess notochord
tissue can induce pituitary duplication, ectopically placed
notochord induces invagination of surface ectoderm in chick-
ens, producing a structure that is morphologically similar to
Rathke’s pouch (Gleiberman et al., 1999). The human cases of
pituitary duplication are morphologically different from the
secondary anterior and intermediate lobes produced in the
absence of noggin in mice. The human duplications are
symmetric around the midline, whereas the mouse noggin−/−
embryos are duplicated in the rostral to caudal dimension. In
addition, the infundibulum is not duplicated in noggin−/−
embryos, while it is consistently duplicated in the reported
human cases. Thus, the human pituitary duplications and the
noggin−/− mouse pituitary duplications are unlikely to arise
from the same mechanism.
This paper highlights the role that noggin performs in
regulating the inductive activity of Bmp4 on Rathke’s pouch. In
addition, it establishes the complicated interplay between the
various signaling factors and their inhibitors that are necessary
for proper pituitary development. Rathke’s pouch is induced in
response to Bmp signaling emanating from the ventral
diencephalon. Disruption in Bmp regulation therefore results
in a severe morphological disruption of Rathke’s pouch.
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